Cargando…

Investigation into problems associated with the endotoxin activity assay

Detalles Bibliográficos
Autores principales:	Matsumoto, N, Takahashi, G, Kojika, M, Ishibe, Y, Tatsuyori, S, Yasushi, S, Inada, SK, Endo, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239247/ http://dx.doi.org/10.1186/cc10373

Ejemplares similares

High mobility group box 1 levels in septic disseminated intravascular coagulation patients undergoing Polymixin-B immobilized fiber-direct hemoperfusion
por: Ishibe, Y, et al.
Publicado: (2012)

Newly developed endotoxin measurement method (endotoxin activity assay) may reflect the severity of sepsis
por: Murayama, H, et al.
Publicado: (2009)

Endotoxin assay with endotoxin scattering photometry is one of the diagnostic markers of sepsis
por: Kase, Y, et al.
Publicado: (2010)

Measuring endotoxin with newly developed endotoxin scattering photometry
por: Kase, Y, et al.
Publicado: (2008)

Assessment of procalcitonin values in deep mycosis associated with high β-D-glucan values
por: Kikuchi, S, et al.
Publicado: (2008)

New sepsis-related marker: endotoxin activity assay
por: Ikeda, T, et al.
Publicado: (2010)

Usefulness of endotoxin activity assay for early diagnosis of sepsis
por: Sekine, S, et al.
Publicado: (2015)

Early diagnosis of sepsis due to Gram-negative infection with the Endotoxin Activity Assay
por: Kang, M, et al.
Publicado: (2014)

Efficacy of the CTR-001 direct hemoperfusion adsorption column in sepsis
por: Suzuki, Y, et al.
Publicado: (2008)

Relationship between serum nitrite/nitrate levels in the early phase of septic acute lung injury and prognosis
por: Sato, M, et al.
Publicado: (2013)

Improving of APACHE II score at the early phase using CTR-001 direct hemoperfusion in patients with severe sepsis and septic shock
por: Suzuki, Y, et al.
Publicado: (2009)

Serum levels of presepsin reffects the APACHE II and SOFA scores in patients with sepsis
por: Sato, R, et al.
Publicado: (2013)

Usefulness of the endotoxin activity assay as a biomarker to assess severity in ICU patients
por: Noguchi, M, et al.
Publicado: (2014)

Endotoxin Activity Assay levels correlate with the microbiological results of Gram-negative organisms in septic patients
por: Tsunoda, M, et al.
Publicado: (2014)

Endotoxin activity assay and polymyxin B hemoperfusion use in a cohort of critically ill patients
por: Cutuli, SL, et al.
Publicado: (2014)

Clinical usefulness of measuring endotoxin activity on ICU admission
por: Murai, A, et al.
Publicado: (2012)

Endotoxin induces conversion of endothelial cells into activated fibroblasts
por: Echeverría, César, et al.
Publicado: (2013)

The effect of endotoxin adsorber haemoperfusion on microcirculation in septic pigs
por: Yeh, Y-C, et al.
Publicado: (2015)

Endotoxin removal by hemoperfusion in septic shock
por: Adamik, B, et al.
Publicado: (2011)

Endotoxin enhances the fibrinolytic activity of monocytes incorporated in a fibrin clot
por: Grosjean, A, et al.
Publicado: (2005)

Prevalence and clinical significance of early endotoxin activity in septic shock patients
por: Bottiroli, M, et al.
Publicado: (2015)

Serum procalcitonin level correlates with endotoxin activity in patients with septic shock
por: Adamik, B, et al.
Publicado: (2015)

Insulin therapy inhibits poly(ADP-ribose)polymerase activation in endotoxin shock
por: Szabo, C, et al.
Publicado: (2007)

Polymyxin B hemoperfusion in high endotoxin activity level septic shock patients
por: Monti, G, et al.
Publicado: (2008)

Anti-endotoxin immunity in abdominal sepsis patients
por: Butyrsky, O, et al.
Publicado: (2011)

Why measure endotoxin in septic shock patients?
por: Monti, G, et al.
Publicado: (2008)

Changes in procalcitonin in septic shock patients treated with endotoxin adsorption therapy
por: Ikeda, T, et al.
Publicado: (2005)

The effect of endotoxin adsorber hemoperfusion on microcirculation in patients with severe sepsis and septic shock
por: Yeh, Y-C, et al.
Publicado: (2015)

Marker or mediator? Changes in endotoxin activity as a predictor of adverse outcomes in critical illness
por: Klein, D, et al.
Publicado: (2005)

Investigation of type II phospholipase A(2 )values and eicosanoid values during polymyxin-B-immobilized fiber direct hemoperfusion of septic shock patients
por: Shouzushima, T, et al.
Publicado: (2009)

The role of plasminogen activator inhibitor 1 measurement with endotoxin adsorption therapy (PMX-DHP) for postoperative septic shock patients
por: Ikeda, T, et al.
Publicado: (2007)

Beneficial effect of sevoflurane on endotoxin-induced pulmonary hypertension
por: Fyntanidou, B, et al.
Publicado: (2010)

Use of extracorporeal endotoxin elimination therapy for septic shock
por: Adamik, BA, et al.
Publicado: (2013)

Microdialysis: an innovative new tool to detect endotoxin tolerance
por: Staubach, K, et al.
Publicado: (2004)

Endotoxin impairs the human pacemaker current I(f)
por: Zorn-Pauly, K, et al.
Publicado: (2008)

Endotoxin adsorption method may affect serum procalcitonin
por: Ikeda, T, et al.
Publicado: (2008)

New diagnostic marker for sepsis: soluble CD14 subtype
por: Shirakawa, K, et al.
Publicado: (2004)

Activated protein C restores kidney function in endotoxin-induced acute renal failure in the rat
por: Almac, E, et al.
Publicado: (2009)

Protective effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on endotoxin-induced acute lung injury in rats
por: Liu, D, et al.
Publicado: (2005)

Clinical evaluation of endotoxin hemoadsorption therapy (PMX-DHP) for hypercytokinemia caused by septic multiple organ failure
por: Ikeda, T, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_cd6g0nem6c821ok9cqv34iaqqd